FdaApplication
BLA 761116
Identifiers
- fda_app_no: BLA761116
Properties
| Property | Value |
|---|---|
| applicant_name | Stemline Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2018-12-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELZONRIS | TAGRAXOFUSP-ERZS | 1,000MCG/1ML | Injection |
1 product